|
|
Volumn 106, Issue 5, 2005, Pages 1513-1514
|
|
Old and new drugs join forces against hematologic malignancies
a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
APOPTOSIS INDUCING FACTOR;
BORTEZOMIB;
CARBANILAMIDE DERIVATIVE;
CASPASE;
CELL ADHESION MOLECULE;
FAS ANTIGEN;
HONOKIOL;
MAGNOLIA GRANDIFLORA EXTRACT;
PLANT EXTRACT;
POLYPHENYLUREA DERIVATIVE;
PROTEASOME INHIBITOR;
PROTEIN INHIBITOR;
UNCLASSIFIED DRUG;
X LINKED INHIBITOR OF APOPTOSIS;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER CELL CULTURE;
CELL CONTACT;
CHINESE MEDICINE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL PROTOCOL;
COMBINATORIAL LIBRARY;
CYTOPATHOGENIC EFFECT;
DRUG CYTOTOXICITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG SELECTIVITY;
ENZYME ACTIVITY;
GENETIC DRIFT;
HEMATOLOGIC MALIGNANCY;
HUMAN;
INNATE IMMUNITY;
MAGNOLIA GRANDIFLORA;
MAGNOLIACEAE;
MULTIPLE MYELOMA;
NOTE;
PLANT ROOT;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN SECRETION;
REGULATORY MECHANISM;
|
|
EID: 23944480905
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood-2005-06-2375 Document Type: Note |
|
Times cited : (1)
|
|
References (3)
|
